Sino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In China

RefinitivMenos de 1 minuto de lectura

Sino Biopharmaceutical Ltd 1177:

TQB2102 INCLUDED IN BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS IN CHINA

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Inicie sesión o cree una cuenta gratuita y permanente para leer esta noticia